Expression of mir-33a/b in hepatoma cells treated with atorvastatin (2012)
Source: Drug Metabolism and Drug Interactions. Conference titles: Santorine Conference Biologie Prospective. Unidade: FCF
Subjects: EXPRESSÃO GÊNICA, COLESTEROL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZAMBRANO, T et al. Expression of mir-33a/b in hepatoma cells treated with atorvastatin. Drug Metabolism and Drug Interactions. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 12 set. 2024. , 2012APA
Zambrano, T., Cerda, A., Hirata, M. H., Hirata, R. D. C., & Salazar, L. A. (2012). Expression of mir-33a/b in hepatoma cells treated with atorvastatin. Drug Metabolism and Drug Interactions. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.NLM
Zambrano T, Cerda A, Hirata MH, Hirata RDC, Salazar LA. Expression of mir-33a/b in hepatoma cells treated with atorvastatin. Drug Metabolism and Drug Interactions. 2012 ; 27( 3): A34 res. B28.[citado 2024 set. 12 ]Vancouver
Zambrano T, Cerda A, Hirata MH, Hirata RDC, Salazar LA. Expression of mir-33a/b in hepatoma cells treated with atorvastatin. Drug Metabolism and Drug Interactions. 2012 ; 27( 3): A34 res. B28.[citado 2024 set. 12 ]